Japan's Takeda Pharmaceutical will hold an investor vote on its $62 billion acquisition of Shire next month and aims to close the deal on Jan. 8, signaling its confidence in securing the required support.
from Business & Finance via Godstime David on Inoreader https://ift.tt/2qIOAnW
via
IFTTT
we need your feedback